WaterStone Capital

WaterStone Capital is a private investment fund manager with intellectual property as the core. It provides financing for Chinese and foreign enterprises with intellectual property content in the form of equity investment, and provides diversified support for enterprises through post-investment management, including cross-border capital operations, business docking, and resource integration. The firm is formed by a team from China and the United States. Its team members have worked in major Chinese and foreign institutions and have complementary advantages. Partners have extensive experience in international mergers and acquisitions, investment management, intellectual property rights, and independent entrepreneurship.

Yang Yigang

Co-Founder, Managing Partner and CEO

1 past transactions

LumiThera

Series B in 2017
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. The company is developing solutions to prevent vision loss and blindness, improve visual function, and stop or slow the progression of blinding diseases of the eye. They delivering photobiomodulation (PBM) treatment for ocular disorders and diseases. LumiThera also focused on treating patients affected by dry age-related macular degeneration. The company’s expertise is in the application of photobiomodulation (PBM), using non-invasive light-emitting diodes (LED) for acute and chronic ocular diseases and disorders. The company was founded in 2013 and is headquartered in Poulsbo, Washington, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.